kidney disease and semaglutide Separate combined effects of and empagliflozin on oxygenation and perfusion in people with type 2 diabetes: a randomised trial | Diabetologia Semaglutide: A New Era in

Retatrutide targets more hormone pathways than nearly any approved weight loss medications

If anything, this experience reinforced how important it is for those of us taking GLP-1 medications to focus on nutrient-dense foods and not just appetite suppression

Of 41 792 patients who discontinued and had a discontinuation weight measurement available, 1-year reinitiation was lower for those without type 2 diabetes (36.3% [95% CI, 35.6%-37.0%]) compared with those with type 2 diabetes (47.3% [95% CI, 46.6%-48.0%])

Unlike in DIRKO mice, jejunal crypt depth failed to expand in GLPDRKO mice, independent of sex (Fig

In contrast, the prototypical GLP-1 analog is liraglutide, also known as Victoza

Lancet 402 , 529544 (2023)